Updates

Quantum Pharma - Soon-to-be prospective PE of 9.9

October 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Quantum has announced the first large-scale NHS homecare contract win for its Biodose Services division. More seem likely. This contract with Yorkshire and Humber NHS Pharmaceutical Purchasing Consortium will require Biodose Services to supply a variety of medicines (including anti-retroviral drugs, tuberculosis treatments, medicines for cystic fibrosis, etc) in pre-filled Biodose trays to 3,000 homecare patients. Annually, 9,500 deliveries will be made. The contract starts in Q4 15 and will initially run for 18 months with an option to extend for two years.Zeus forecasts £12.1m pretax profit/eps 7.9p for this year to end January, with a modest upgrade to £19.7m/12.6p and £24.8m/15.8p over the following two years. Buy. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Boohoo.com

Innovation

Quantum Pharma - Gain since our February write up: 75% (October 2017)

Quantum Pharma - Bid from Clinigen (September 2017)

Quantum Pharma (June 2017)

Quantum Pharma - Considerably less flannel from new CEO (February 2017)

Quantum Pharma - Sweep of board and placing (November 2016)

Quantum Pharma (June 2016)

Quantum Pharma (March 2016)

Quantum Pharma - Five more products now approved (November 2015)

Quantum Pharma (September 2015)

Quantum Pharma - Explosive growth trajectory (June 2015)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X